Firefly Neuroscience (AIFF) Cash from Operations (2010 - 2026)

Firefly Neuroscience has reported Cash from Operations for 17 years, with the latest figure at -$1.8 million in Q2 2026.

• On a quarterly basis, Cash from Operations rose 26.78% year-over-year to -$1.8 million in Q2 2026; TTM through Jun 2026 was -$7.0 million, a 42.96% increase from a year earlier, with the FY2025 full-year figure at -$8.2 million, down 33.13% from the prior year.
• Cash from Operations was -$1.8 million for Q2 2026 at Firefly Neuroscience, up from -$1.9 million in the prior quarter.
• The five-year high for Cash from Operations was $491536.0 in Q3 2023, with the low at -$4.9 million in Q3 2024.
• Average Cash from Operations over 5 years is -$1.8 million, with a median of -$1.8 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Cash from Operations sank 1295.69% in 2022, then soared 166.09% in 2023.
• Over 5 years, Cash from Operations stood at -$2.6 million in 2022, then jumped by 80.27% to -$510000.0 in 2023, then plunged by 868.04% to -$4.9 million in 2024, then jumped by 63.44% to -$1.8 million in 2025, then grew by 3.05% to -$1.8 million in 2026.
• The last three Cash from Operations figures came in at -$1.8 million (Q2 2026), -$1.9 million (Q1 2026), and -$1.8 million (Q4 2025), per Business Quant data.